Skip to main content

Remote Access to Urinary Incontinence Treatments Aids Women Veterans

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 22, 2025.

via HealthDay

MONDAY, Sept. 22, 2025 -- Receiving remote behavioral urinary incontinence (UI) treatment through either a mobile health app or video visit improves symptoms among women veterans, according to a study published online Sept. 16 in JAMA Network Open.

Alayne D. Markland, D.O., from the Department of Veterans Affairs in Birmingham, Alabama, and colleagues compared the effectiveness of evidence-based UI behavioral treatment with or without booster visits delivered through two remote modalities. The analysis included 286 women veterans (mean age, 53.2 years) with UI who were randomly assigned to receive behavioral treatment through a mobile health UI app (MyHealtheBladder; 147 women) or a video visit (139 women).

The researchers found that at 12 weeks, International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) scores for the UI app group decreased −3.6 points compared with −2.3 points for the video visit group. A sequential addition of a video booster visit for nonresponders in the UI app group at eight weeks did not significantly change ICIQ-UI SF scores. In the video visit nonresponder group, the booster video visit similarly did not significantly change ICIQ-UI SF scores. At four weeks, the change in ICIQ-UI SF scores for the UI app reached the minimal clinical importance difference threshold (2.52 points), which the video visit group did not reach until 24 weeks.

“Further research could extend these modalities to broaden access to behavioral UI treatment,” the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Advances in Cancer Research Described in 15th Cancer Progress Report

MONDAY, Sept. 22, 2025 -- Progress in cancer research, including approval of 20 new anticancer therapeutics in the past year, is described in the 15th edition of the AACR Cancer...

Population Aging Contributes to Burden of Musculoskeletal Disorders

MONDAY, Sept. 22, 2025 -- Population aging is the largest contributor to the increasing burden of musculoskeletal (MSK) disorders in about one-third of countries, according to a...

Circulating Tumor HPV DNA Can ID HPV+OPSCC Years Before Diagnosis

MONDAY, Sept. 22, 2025 -- Circulating tumor human papillomavirus DNA (ctHPVDNA) can be detected in the blood years prior to HPV-associated oropharyngeal squamous cell carcinoma...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.